Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0000890465-13-000025
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-09-30 18:23:38
Reporting Period:
2013-09-26
Filing Date:
2013-09-30
Accepted Time:
2013-09-30 18:23:38
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
890465 Nps Pharmaceuticals Inc NPSP Biological Products, (No Disgnostic Substances) (2836) 870439579
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1365343 Francois Nader 550 Hills Drive
Bedminster NJ 07921
President, Ceo And Director Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-09-26 19,350 $5.05 236,828 No 4 M Direct
Common Stock Acquisiton 2013-09-26 992 $5.85 237,820 No 4 M Direct
Common Stock Disposition 2013-09-26 143,503 $33.07 94,317 No 4 S Direct
Common Stock Disposition 2013-09-26 6,497 $33.60 87,820 No 4 S Direct
Common Stock Acquisiton 2013-09-27 17,008 $5.85 104,828 No 4 M Direct
Common Stock Acquisiton 2013-09-27 16,650 $6.16 121,478 No 4 M Direct
Common Stock Acquisiton 2013-09-27 9,800 $5.71 131,278 No 4 M Direct
Common Stock Disposition 2013-09-27 43,458 $32.36 87,820 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options Disposition 2013-09-26 19,350 $0.00 19,350 $5.05
Common Stock Stock Options Disposition 2013-09-26 992 $0.00 992 $5.85
Common Stock Stock Options Disposition 2013-09-27 17,008 $0.00 17,008 $5.85
Common Stock Stock Options Disposition 2013-09-27 16,650 $0.00 16,650 $6.16
Common Stock Stock Options Disposition 2013-09-27 9,800 $0.00 9,800 $5.71
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
3,150 2018-07-15 No 4 M Direct
21,508 2018-10-15 No 4 M Direct
4,500 2018-10-15 No 4 M Direct
5,850 2019-01-15 No 4 M Direct
82,826 2019-01-20 No 4 M Direct
Footnotes
  1. The shares were sold pursuant to a predefined price target in a trading plan qualified under Rule 10b5-1 of the Securities Exchange Act of 1934, as amended, that was effective September 26, 2013.
  2. The price shown above represents the weighted average price of the shares sold. The range of sales prices was $32.51 and $33.50. The Reporting Person will provide to the Issuer, any security holder of the Issuer, or the SEC Staff, upon request, information regarding the number of shares sold at each price within the range of prices actually paid.
  3. The price shown above represents the weighted average price of the shares sold. The range of sales prices was $33.52 and $33.69. The Reporting Person will provide to the Issuer, any security holder of the Issuer, or the SEC Staff, upon request, information regarding the number of shares sold at each price within the range of prices actually paid.
  4. The price shown above represents the weighted average price of the shares sold. The range of sales prices was $32.05 and $32.77. The Reporting Person will provide to the Issuer, any security holder of the Issuer, or the SEC Staff, upon request, information regarding the number of shares sold at each price within the range of prices actually paid.
  5. On July 15, 2008, the Reporting Person received a grant of 22,500 stock options under the Issuer's 1998 Stock Option Plan. The options become exercisable based on the following vesting schedule: 28% on the first anniversary of the grant and 2% each month thereafter.
  6. On October 15, 2008, the Reporting Person received a grant of 22,500 stock options under the Issuer's 1998 Stock Option Plan. The options become exercisable based on the following vesting schedule: 28% on the first anniversary of the grant and 2% each month thereafter.
  7. On January 15, 2009, the Reporting Person received a grant of 22,500 stock options under the Issuer's 1998 Stock Option Plan. The options become exercisable based on the following vesting schedule: 28% on the first anniversary of the grant and 2% each month thereafter.
  8. On January 20, 2009, the Reporting Person received a grant of performance based options under the Issuer's 1998 Stock Option Plan. The actual number of options received was 92,626, which was determined based on the performance of the Issuer's common stock relative to the performance of stock comprising a selected market index. 50% of such options vested and became exercisable on the second anniversary of the date of grant and the remaining 50% of such options vested and became exercisable on the third anniversary of the date of grant.